Literature DB >> 10391901

Phospholipase C-beta1 directly accelerates GTP hydrolysis by Galphaq and acceleration is inhibited by Gbeta gamma subunits.

P Chidiac1, E M Ross.   

Abstract

Phospholipase C-beta, the principal effector protein regulated by Galphaq, has been shown to increase the agonist-stimulated, steady-state GTPase activity of Gq in proteoliposomes that contain both heterotrimeric Gq and m1 muscarinic receptor. We now use a moderately stable complex of R183C Galphaq bound to GTP to show that PLC-beta1 acts directly as a GTPase-activating protein (GAP) for isolated Galphaq in a membrane-free system. PLC-beta1 accelerated the hydrolysis of GalphaqR183C.GTP up to 20-fold. The Km was 1.5 nM, which is similar both to the EC50 with which R183C and wild type Galphaq activate PLC-beta1 and to the EC50 with which PLC-beta1 acts as a Gq GAP in the vesicle-based assay. The Galphaq GAP activity of RGS4 can also be quantitated by this assay; it accelerated hydrolysis of bound GTP about 100-fold. The Gq GAP activities of both PLC-beta1 and RGS4 are blocked by Gbeta gamma subunits, probably by a competitive mechanism. These data suggest either that the Gbeta gamma subunits are not continuously required for receptor-catalyzed GDP/GTP exchange during steady-state GTP hydrolysis or that GAPs, either PLC-beta or RGS proteins, can substitute for Gbeta gamma in this set of reactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391901     DOI: 10.1074/jbc.274.28.19639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

2.  Calmodulin potentiates G beta gamma activation of phospholipase C-beta3.

Authors:  Jennifer S McCullar; Dean A Malencik; Walter K Vogel; Kristi M Crofoot; Sonia R Anderson; Theresa M Filtz
Journal:  Biochem Pharmacol       Date:  2006-10-13       Impact factor: 5.858

3.  Kinetic diversity in G-protein-coupled receptor signalling.

Authors:  Vladimir L Katanaev; Matey Chornomorets
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

Review 4.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

5.  PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells.

Authors:  C S Walker; T Sundrum; D L Hay
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

6.  Structural and functional analysis of the regulator of G protein signaling 2-gαq complex.

Authors:  Mark R Nance; Barry Kreutz; Valerie M Tesmer; Rachel Sterne-Marr; Tohru Kozasa; John J G Tesmer
Journal:  Structure       Date:  2013-02-21       Impact factor: 5.006

7.  Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG.

Authors:  Ancy D Nalli; Divya P Kumar; Othman Al-Shboul; Sunila Mahavadi; John F Kuemmerle; John R Grider; Karnam S Murthy
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

8.  Atypical activation of the G protein Gαq by the oncogenic mutation Q209P.

Authors:  Marcin Maziarz; Anthony Leyme; Arthur Marivin; Alex Luebbers; Prachi P Patel; Zhe Chen; Stephen R Sprang; Mikel Garcia-Marcos
Journal:  J Biol Chem       Date:  2018-10-23       Impact factor: 5.157

Review 9.  Coordinating speed and amplitude in G-protein signaling.

Authors:  Elliott M Ross
Journal:  Curr Biol       Date:  2008-09-09       Impact factor: 10.834

10.  Probing the mutational landscape of regulators of G protein signaling proteins in cancer.

Authors:  Vincent DiGiacomo; Marcin Maziarz; Alex Luebbers; Jillian M Norris; Pandu Laksono; Mikel Garcia-Marcos
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.